legislation: 110-sconres-88
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110-sconres-88 | 110 | sconres | 88 | A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. | Health | 2008-06-10 | 2008-06-10 | Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5455-5456) | Senate | Sen. Cornyn, John [R-TX] | TX | R | C001056 | 2 | Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians unless it holds a public comment period on the issue and can document evidence of adverse events and other safety issues to justify such policy. | 2022-02-03T05:09:47Z |